ArticleThe oncologist2022

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination.

Won Sriwijitalai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.